Combination drug strategy produces promising results by hyperactivating oncogenic signaling July 26, 2024 Health Trends, Health Trends - UK FGF2 impairs cell cycle progression in K-Ras-driven cancer cells. Serum-starved Y1D1 cells were stimulated by 10% serum with or without 10 ng·mL−1 FGF2 to re-entry the cell cycle. Cells were subjected to a BrdU pulse 30… Source link
July 26, 2024 Health Trends, Health Trends - UK FGF2 impairs cell cycle progression in K-Ras-driven cancer cells. Serum-starved Y1D1 cells were stimulated by 10% serum with or without 10 ng·mL−1 FGF2 to re-entry the cell cycle. Cells were subjected to a BrdU pulse 30… Source link
